REGISTRATION IS OPEN! Learn how the new PMPRB amendments and guidelines will affect your pharmaceutical pricing, negotiations and reimbursement Join PDCI Market Access Inc., Canada’s leading pricing and reimbursement consultancy, for industry-only sessions on the pricing guidelines, led by senior members ...
REGISTRATION IS OPEN! Learn how the new PMPRB amendments and guidelines will affect your pharmaceutical pricing, negotiations and reimbursement Join PDCI Market Access Inc., Canada’s leading pricing and reimbursement consultancy, for industry-only sessions on the pricing guidelines, led by senior members of the PDCI team ...
PDCI and 3Sixty Public Affairs invites its industry clients, partners and colleagues to participate in a webinar on September 4, 2019 between 2:00pm to 3:00pm. This important session will cover the PMPRB price regulatory amendments and share insights on their implications for pharmaceutical market access. The session will provide an overview of ...
Mark down June 26th, 2019 in your calendars. It is now widely expected the patented medicines price regulations will be in Canada Gazette Part II (CGII), volume 151 No.13, which will be released on June 26th. Draft PMPRB Guidelines for consultation will likely be published immediately following CGII publication. Comments earlier this week from Federal Health Minister Petitpas-Taylor, appeared to confirm these expectations. When asked in an interview surrounding when changes to the ...
PDCI Market Access is delighted to participate in the 4th Annual Canadian Institute’s Pharma Symposium. The Pharma Symposium brings together leading stakeholders from pharmaceutical manufacturers, public/private payers, agencies, regulatory bodies and patient groups to analyze the key issues facing the industry in today’s complex environment. Participants will gain insights as ...
Join us for a webinar on Dec 06, 2017 at 2:00 PM EST. Register now! Join PDCI’s Founder and Principal Consultant, Neil Palmer on this industry only webinar as he discusses the proposed amendments to the Patented Medicines Regulations as published in Canada Gazette Part 1 on December 2, 2017. What ...
PDCI Market Access Webinar: New INESSS Submission Guidelines and Implementation of Pre-NOC Review Procedure
On June 2, 2017, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released new submission guidelines, including a pre-NOC review procedure, to be implemented immediately. PDCI Market Access Inc., Canada’s leading pricing and reimbursement consultancy, will be hosting a free webinar for industry (manufacturers only) on these new ...
PDCI Market Access Webinar: Information Session for Industry on Proposed Amendments to Patented Medicines Regulations
On Tuesday, May 16, 2017, Federal Health Minister Hon. Jane Philpott opened consultations on a suite of amendments to the Patented Medicines Regulations that will have significant effects on how patented drug prices are regulated in Canada. The implementation of these proposed amendments could represent the most important changes in ...
Join PDCI at 3rd Annual Canadian Institute Pharma Symposium PDCI Market Access is delighted to participate in the 3rd Annual Canadian Institute’s Pharma Symposium. The Pharma Symposium brings together leading stakeholders in pharmaceutical market access & policy to analyze the key issues facing the industry in today’s complex environment. Participants will ...
PDCI Market Access WEBINAR ‒ Information Session on the PMPRB Guidelines Modernization Discussion Paper
*Tuesday, August 17th Webinar CANCELLED* We regret to inform you that the webinar session on Wednesday, August 17th, 2016 from 10:00 a.m. to 12:00 p.m. (noon) is cancelled due to unforeseen technical issues. We wanted to give as much notice as possible so individuals can register for the alternate date (Tuesday, ...